Campbell Soup Slips After Slashing Guidance


Bright and early this morning, Campbell Soup Co. (CPB) lowered its forecast for fiscal 2010 sales. The company now expects sales to grow 2.5% to 3.5% during the current fiscal year, down from its previous projection for sales growth of 4% to 5%. However, earnings for 2010 are still expected to rise 9% to 11% on an annualized basis from $2.21 per share in fiscal 2009.

Campbell also announced this morning that it's launching "a comprehensive plan to boost the performance of its condensed soup portfolio" in the U.S. More than 60% of the company's condensed line will be spruced up with product improvements, sodium reductions, updated packaging, and a fresh marketing approach.


"We are committed to accelerating the performance of our existing portfolio, most notably in U.S. soup, and continuing to lay the foundation for superior long-term growth," stated President and CEO Doug Conant. "With the improvements and innovations we've made over the past several years and our plans for next year, we will be able to unleash soup's full competitiveness against the simple meals category."

CPB has sagged in today's trading as investors consider the company's updated sales forecast. The stock is struggling to maintain a foothold atop its 10-week and 20-week moving averages; these formerly supportive trendlines haven't been toppled on a weekly closing basis since mid-December 2009.

If the equity's reaction to today's news seems somewhat muted -- with the shares just fractionally lower at last check -- it's because traders have already priced in plenty of skepticism. Short interest on CPB rose by nearly 33% during the past month, and now accounts for a healthy 4.1% of the stock's float. Analysts are similarly unimpressed, with Zacks reporting 11 holds and just five buy ratings.

With CPB slated to report its fiscal second-quarter earnings next Monday, these low expectations could be a boon for the stock. The food firm has exceeded analysts' profit expectations in each of the previous four reporting periods, and another upside surprise could shake loose some of the weaker bearish hands.

Elizabeth Harrow is a senior equities analyst and financial writer in the research department at Schaeffer's Investment Research. She is featured in the video series Schaeffer's Daily Q&A on SchaeffersResearch.com.

Symbol Lookup
IndexesChangePrice
DJIA-135.4712,754.99
NASDAQ-23.832,903.40
S&P 500-12.291,339.66

Last updated: February 10, 2012: 02:03 PM

Hot Stocks

General Electric

18.805-0.325(-1.70)

Alcoa

10.255-0.385(-3.62)

Apple Inc

493.98+0.81(+0.16)

Google Inc 'A'

605.34-6.12(-1.00)

Bank of America

8.065-0.115(-1.41)

Wal-Mart Stores

61.50-0.46(-0.74)

Exxon Mobil Corp

83.51-1.37(-1.61)

Ford

12.44-0.25(-1.97)

Citigroup

32.89-0.77(-2.29)

IBM

191.85-1.28(-0.66)

Yahoo

16.18+0.18(+1.12)

Starbucks

48.65-0.55(-1.12)

Microsoft

30.54-0.23(-0.75)

Home Depot

45.01-0.26(-0.57)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328900595964 ms.